comparative effectiveness

Original Research

The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting

05/03/2017

Nathan B. Parsons ;

Michelle Skornicki ;

Ira Kraus ;

Michael Leon Sabolinski , MD;

05/03/2017

Wounds

Research in Review

Treatment Better Than Observation for Older Patients With Esophageal Cancer

05/03/2017

JCP Editors

Patients aged 80 years or older with early-stage esophageal cancer who received treatment had an increased 5-year overall survival (OS) compared with those who received no treatment or observation alone,...

...

05/03/2017

Journal of Clinical Pathways

Research in Review

Leukemia Survival Outcomes Differ Between Sites of Care

04/11/2017

JCP Editors

Sites of care may help explain survival differences between children and adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), according to research published...

Sites...

04/11/2017

Journal of Clinical Pathways

Research in Review

Daratumumab Cost-Effective for Refractory Multiple Myeloma

04/10/2017

JCP Editors

Single agent daratumumab may serve as a more cost-effective treatment strategy than pomalidomide for patients with refractory multiple myeloma. ----- Related Content Daratumumab improves progression-free survival...

Single...

04/10/2017

Journal of Clinical Pathways

Research in Review

New Drug Improves PFS for Patients With ALK-Positive NSCLC

04/10/2017

JCP Editors

Patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) live significantly longer without disease progression when treated with a new drug compared with those treated with...

...

04/10/2017

Journal of Clinical Pathways

Research in Review

Small Study Suggests Nivolumab Does Not Improve Outcomes in Patients With Lung Cancer and Liver Metastases

03/16/2017

JCP Editors

None of the patients in a study with lung cancer and hepatic metastases experienced an objective response in their liver tumors after anti-PD1 therapy, according to research presented at ASCO’s Society for...

None...

03/16/2017

Journal of Clinical Pathways

Research in Review

Single, High-Dose Brachytherapy Effective in Patients With Localized Prostate Cancer

03/06/2017

JCP Editors

High-dose-rate brachytherapy administered in a single treatment may be a safe and effective alternative for patients with non-metastatic prostate cancer, according to a new study. ----- Related Content Surgery...

...

03/06/2017

Journal of Clinical Pathways

Research in Review

Study: Newer NSCLC Therapies Have Limited Real-World Survival Benefit, High Costs

02/14/2017

JCP Editors

Therapies recently approved to treat advanced-stage non-small cell lung cancer (NSCLC) confer an average of 1.5-month survival increase and an $8,000 increase in outpatient spending per patient, according to a study...

...

02/14/2017

Journal of Clinical Pathways

Department

Symptoms of Menopause Influence Tamoxifen Adherence Rates

02/13/2017

JCP Editors

Common menopausal symptoms such as nausea and headaches can be used as predictive tools for adherence to the aromatase inhibitor tamoxifen, according to an analysis of data from the International Breast Cancer...

...

02/13/2017

Journal of Clinical Pathways

Research in Review

Response to Chemo Helps Decide Optimal Treatment Course for Patients With Laryngeal Cancer

02/10/2017

JCP Editors

Response to a single dose of neoadjuvant chemotherapy indicates the optimal treatment course for patients with laryngeal cancer, according to a study published in JAMA Otolaryngology (published online February 2,...

...

02/10/2017

Journal of Clinical Pathways